Morgan Curtis

Author PubWeight™ 0.91^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.	Cancer	2014	0.91